Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-25 @ 8:36 PM
Study NCT ID:
NCT04457869
Status:
UNKNOWN
Last Update Posted:
2020-10-22
First Post:
2020-07-01
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of F520 in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) or Secondary Central Nervous System Lymphoma (SCNSL)
Sponsor:
Shandong New Time Pharmaceutical Co., LTD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-07-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-07-01
First Submit QC Date:
None
Study First Post Date:
2020-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-19
Last Update Post Date:
2020-10-22
Last Update Post Date Type:
ACTUAL